Vol 4 Issue 3

Supply Chain Management Part 1: Getting it Right from the Start

Mar 2018

Guest Editor:

Jean Stanton, Director, Commercial Apheresis Operations

Expert Insight

Making the grade: untangling the myths of raw materials used for the manufacture of cell- & gene-based medicinal products

Sarah Robinson,

Scott R Burger,

Christopher Bravery

6 April 2018

Expert Insight

Innovation in Management as a Tool for Accelerated Translation of Advanced Therapies

Nicholas Medcalf

5 April 2018

Expert Insight

Innovator Insight

Addressing Particulates, Extractables & Leachables & the Quality of Single-Use Systems for Cell & Gene Therapy Manufacturing

Dominic Clarke

16 April 2018

Innovator Insight

The Evolution of Product Transfer and Labeling in Cellular Therapy

Lizette Caballero

16 April 2018

Innovator Insight

Raw Materials for Cell & Gene Therapy: Getting it Right from the Start

Feb 2017

Optimizing the Cell Collection Network to Support the Commercialization of Cell & Gene Therapies

Amy Hines,

Kimberly Kasow,

Sandra Hoffmann

5 June 2018

Interview

Understanding the Role of Critical Quality Attributes along the Commercialization Pathway

Anna Gilbert

5 April 2018

Interview

Commercial Insights

Cell & Gene Therapy Commercial Insight – March 2018

Mark Curtis,

Richard Philipson

16 April 2018

Commercial Insights

“One Word: Plastics” – The Role of Material Science in Cell Therapy Manufacturing

Natasha Boghosian, Consultant at Integrated Project Management Company, Inc.

Katie Campbell, Senior Research Engineer II at Saint-Gobain

4 April 2017

Webinar

Watch now

GMP raw materials for cell therapy manufacture: what, when and how?

Jean Stanton, Director, Commercial Apheresis Operations

John Paul Tomtishen III, Director of Manufacturing, Technical Operations at Legend Biotech Co.

Diane Wotta, Senior Director, Quality & Regulatory Affairs at Bio-Techne - R&D Systems

Dr. Sadik Kassim, CTO, Vor BioPharma

22 February 2018

Webinar

Watch now

Overcoming challenges with the supply of plasmid DNA & other raw materials for gene therapy manufacture

James Brown, Vice President, Corporate Development at Aldevron LLC

Maritza McIntyre, Chief Development Officer at StrideBio Inc

Curran Simpson, Senior Vice President, Technical Operations at Regenxbio, Inc

Jung Lee, Business Development Consultant at AskBio

Richard Snyder, CSO at Thermo Fisher Scientific

17 April 2018

Webinar

Watch now

Challenges of cell therapy manufacturing: automation and disposables – the hand and the glove

Natasha Boghosian, Consultant at Integrated Project Management Company, Inc.

Brian Hanrahan, Biotech Program Director at StarFish Medical

10 May 2018

Webinar

Watch now

CELL & GENE THERAPY INSIGHTS

Mar 2018. Vol 4 Issue 3

FEATURING

Spotlight

Supply Chain Management Part 1: Getting it Right from the Start

Expert Insight

Making the grade: untangling the myths of raw materials used for the manufacture of cell- & gene-based medicinal products

Innovation in Management as a Tool for Accelerated Translation of Advanced Therapies

Innovator Insight

Addressing Particulates, Extractables & Leachables & the Quality of Single-Use Systems for Cell & Gene Therapy Manufacturing

The Evolution of Product Transfer and Labeling in Cellular Therapy

Spotlight

Raw Materials for Cell & Gene Therapy: Getting it Right from the Start

Optimizing the Cell Collection Network to Support the Commercialization of Cell & Gene Therapies

Understanding the Role of Critical Quality Attributes along the Commercialization Pathway

Other articles

Commercial Insights

Cell & Gene Therapy Commercial Insight – March 2018

Webinars

“One Word: Plastics” – The Role of Material Science in Cell Therapy Manufacturing

GMP raw materials for cell therapy manufacture: what, when and how?

Overcoming challenges with the supply of plasmid DNA & other raw materials for gene therapy manufacture

Challenges of cell therapy manufacturing: automation and disposables – the hand and the glove